239
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Bioadhesive properties of poly(anhydride) nanoparticles coated with different molecular weights chitosan

, , , , &
Pages 455-463 | Received 30 Nov 2010, Accepted 28 Mar 2011, Published online: 11 May 2011

References

  • Agüeros M, Campanero MA, Salman H, Quincoces G, Peñuelas I, Irache JM. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. Eur J Pharm Sci 2009; 37(3–4)231–40
  • Ambruosi A, Yamamoto H, Kreuter J. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats. J Drug Target 2005; 13(10)535–42
  • Arbós P, Campanero MA, Arangoa MA, Renedo MJ, Irache JM. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J Control Release 2003; 89(1)19–30
  • Arbos P, Wirth M, Arangoa MA, Gabor F, Irache JM. Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J Control Release 2002; 83(3)321–30
  • Aumelas A, Serrero A, Durand A, Dellacherie E, Leonard M. Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems. Colloids Surf B 2007; 59(1)74–80
  • Bernkop-Schnürch A. Thiomers: A new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005; 57(11)1569–82
  • Bernkop-Schnürch A, Hornof M, Guggi D. Thiolated chitosans. Eur J Pharm Biopharm 2004; 57(1)9–17
  • Bernkop-Schnürch A, Hornof M, Zoidl T. Thiolated polymers-thiomers: Synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 2003; 260(2)229–37
  • Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: A new generation of mucoadhesive polymers?. Pharm Res 1999; 16(6)876–81
  • Bravo-Osuna I, Schmitz T, Bernkop-Schnürch A. Elaboration and characterization of thiolated chitosan coated acrylic nanoparticles. Int J Pharm 2006; 316(1–2)170–5
  • Bravo-Osuna I, Vauthier C, Farabollini A, Millotti G, Ponchel G. Effect of chitosan and thiolated chitosan coating on the inhibition behaviour of PIBCA nanoparticles against intestinal metallopeptidases. J Nanopart Res 2008; 10(8)1293–301
  • Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007; 28(13)2233–43
  • Cerchiara T, Luppi B, Chidichimo G, Bigucci F, Zecchi V. Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems. Eur J Pharm Biopharm 2005; 61(3)195–200
  • Choi SW, Kim JH. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007; 122(1)24–30
  • Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization. J Control Release 2001; 75(3)409–19
  • Damge C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988; 37(2)246–51
  • Damge C, Vranckx H, Balschmidt P, Couvreur P. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J Pharm Sci 1997; 86(12)1403–9
  • Elhassan IM, Bernkop-Schnürch A. Controlled drug delivery systems based on thiolated chitosan microspheres. Drug Dev Ind Pharm 2005; 31(6)557–65
  • Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution. Int J Pharm 2008; 349(1–2)249–55
  • Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. Topical use of chitosan in ophthalmology: Tolerance, assessment and evaluation of precorneal retention. Int J Pharm 1999; 180(2)185–93
  • Fernandez-Urrusuno R, Romani D, Calvo P, Vila-Jato JL, Alonso MJ. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharma Sci 1999; 9: 429–36
  • Florence AT. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual. Pharm Res 1997; 14(3)259–66
  • Föger F, Schmitz T, Bernkop-Schnürch A. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated choosing. Biomaterials 2006; 27: 4250–5
  • Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 1990; 7(5)491–5
  • Huang M, Wu W, Qian J, Wan DJ, Wei XL, Zhu JH. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles. Acta Pharmacol Sin 2005; 26: 1512–18
  • Imam ME, Hornof M, Valenta C, Reznicek G, Bernkop-Schnürch A. Evidence for the interpenetration of mucoadhesive polymers into the mucus gel layer. STP Pharma Sci 2003; 13(3)171–6
  • Kast CE, Bernkop-Schnürch A. Thiolated polymers – thiomers: Development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 2001; 22(17)2345–52
  • Ladaviere C, Lorenzo C, Elaissari A, Mandrand B, Delair T. Electrostatically driven immobilization of peptides onto (maleic anhydride-alt-methyl vinyl ether) copolymers in aqueous media. Bioconjugate Chem 2000; 11(2)146–52
  • Lee DW, Shirley SA, Lockey RF, Mohapatra SS. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res 2006; 7(1)112
  • Leitner VM, Walker GF, Bernkop-Schnürch A. Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 2003; 56(2)207–14
  • Lichen Y, Jieying D, Chunbai H, Liming C, Chunhua Y. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009; 30(29)5691–700
  • Maculotti K, Genta I, Perugini P, Imama M, Bernkop-Schnürch A, Pavanetto F. Preparation and in vitro evaluation of thiolated chitosan nanoparticles. J Microencapsulation 2005; 22(5)459–70
  • Muzzarelli RA. Colorimetric determination of chitosan. Anal Biochem 1998; 260(2)255–7
  • Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery. Int J Pharm 2005; 301(1–2)268–76
  • Perera G, Greindl M, Palmberger TF, Bernkop-Schnürch A. Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestine. Drug Deliv 2009; 16(5)254–60
  • Ponchel G, Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 1998; 34(2–3)191–219
  • Porfire AS, Zabaleta V, Gamazo C, Leucuta SE, Irache JM. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. Int J Pharm 2010; 390(1)37–44
  • Richert L, Lavalle P, Payan E, Shu XZ, Prestwich GD, Stoltz JF, Schaaf P, Voegel JC, Picart C. Layer by layer buildup of polysaccharide films: Physical chemistry and cellular adhesion aspects. Langmuir 2004; 20(2)448–58
  • Sahana DK, Mittal G, Bhardwaj V, Kumar MN. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 2008; 97(4)1530–42
  • Salman HH, Gamazo C, Campanero MA, Irache JM. Salmonella-like bioadhesive nanoparticles. J Control Release 2005; 106(1–2)1–13
  • Salman HH, Gamazo C, Campanero MA, Irache JM. Bioadhesive mannosylated nanoparticles for oral drug delivery. J Nanosci Nanotechnol 2006; 6(9–10)3203–9
  • Shantha KL, Harding ORK. Synthesis and characterization of chemically modified chitosan microspheres. Carbohydr Polym 2002; 48(3)247–53
  • Soares AF, Carvalho A, Veiga F. Oral administration of peptides and proteins: Nanoparticles and cyclodextrins as biocompatible delivery systems. Nanomedicine 2007; 2(2)183–202
  • Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Del Rev 2005; 57(11)1583–94
  • Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 2001; 52 (2)117–26
  • Van der Merwe SM, Verhoef JC, Kotze AF, Junginger HE. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations. Eur J Pharm Biopharm 2004; 57(1)85–91
  • Wischke C, Borchert HH. Increased sensitivity of chitosan determination by a dye binding method. Carbohydr Res 2006; 341(18)2978–9
  • Yoncheva K, Lizarraga E, Irache JM. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): Preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci 2005; 24(5)411–19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.